Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6717)
All Articles published online
|
Publishing Process of This Article
|
Jul 27, 2014 (publication date) through Dec 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cocciolillo S, Parruti G, Marzio L. CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. World J Hepatol 2014; 6(7): 496-503 [PMID: 25068001 DOI: 10.4254/wjh.v6.i7.496] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v6/i7/496.htm |
| Number | Citing Articles |
| 1 |
Viera Kupčová, Michaela Fedelešová, Jozef Bulas, Petra Kozmonová, Ladislav Turecký. Overview of the Pathogenesis, Genetic, and Non-Invasive Clinical, Biochemical, and Scoring Methods in the Assessment of NAFLD. International Journal of Environmental Research and Public Health 2019; 16(19): 3570 doi: 10.3390/ijerph16193570
|
| 2 |
Tammy L. Kindel, Rama Rao Ganga, John Wilder Baker, Sabrena F. Noria, Daniel B. Jones, Philip Omotosho, Erick T. Volckmann, Noel N. Williams, Dana A. Telem, Anthony T. Petrick, Jon C. Gould. American Society for Metabolic and Bariatric Surgery: Preoperative Care Pathway for Laparoscopic Roux-en-Y Gastric Bypass. Surgery for Obesity and Related Diseases 2021; 17(9): 1529 doi: 10.1016/j.soard.2021.05.011
|
| 3 |
Raluca Lupușoru, Ioan Sporea, Iulia Rațiu, Diana Lungeanu, Alina Popescu, Mirela Dănilă, Ruxandra Mare, Luciana Marc, Andrada Lascău, Tudor Voicu Moga, Felix Bende, Ana-Maria Ghiuchici, Roxana Șirli. Contrast-Enhanced Ultrasonography with Arrival Time Parametric Imaging as a Non-Invasive Diagnostic Tool for Liver Cirrhosis. Diagnostics 2022; 12(12): 3013 doi: 10.3390/diagnostics12123013
|
| 4 |
C.A. Marschner, L. Zhang, V. Schwarze, W. Völckers, M.F. Froelich, N. von Münchhausen, M.L. Schnitzer, T. Geyer, M.P. Fabritius, J. Rübenthaler, D.-A. Clevert. The diagnostic value of contrast-enhanced ultrasound (CEUS) for assessing hepatocellular carcinoma compared to histopathology; a retrospective single-center analysis of 119 patients1. Clinical Hemorheology and Microcirculation 2021; 76(4): 453 doi: 10.3233/CH-209221
|
| 5 |
Lokesh Basavarajappa, Jihye Baek, Shreya Reddy, Jane Song, Haowei Tai, Girdhari Rijal, Kevin J. Parker, Kenneth Hoyt. Multiparametric ultrasound imaging for the assessment of normal versus steatotic livers. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-82153-z
|
| 6 |
Kazunori Kawaguchi, Yoshio Sakai, Takeshi Terashima, Tetsuhiro Shimode, Akihiro Seki, Noriaki Orita, Yumie Takeshita, Tetsuro Shimakami, Hajime Takatori, Kuniaki Arai, Kazuya Kitamura, Taro Yamashita, Tatsuya Yamashita, Masayuki Takamura, Eishiro Mizukoshi, Toshinari Takamura, Masao Honda, Takashi Wada, Shuichi Kaneko. Decline in serum albumin concentration is a predictor of serious events in nonalcoholic fatty liver disease. Medicine 2021; 100(31): e26835 doi: 10.1097/MD.0000000000026835
|
| 7 |
Jiqing Xuan, Yuli Chen, Leilei Zhu, Yuan Guo, Liming Deng, Yuanyi Zheng, Zhaoxia Wang, Zhigang Wang, Meng Ao. Ultrasound molecular imaging with cRGD-PLGA-PFOB nanoparticles for liver fibrosis staging in a rat model. Oncotarget 2017; 8(65): 108676 doi: 10.18632/oncotarget.21358
|
| 8 |
Jiajia Yang, Liwu Lin, Ensheng Xue, Dengke Hong, Yan Yang, Meifang Xu, Zhikui Chen. Can Nonfibrotic Nonalcoholic Steatohepatitis Be Effectively Identified by Supersonic Shear Imaging?. Analytical Cellular Pathology 2019; 2019: 1 doi: 10.1155/2019/2013674
|
| 9 |
Chimeddulam Dalaijamts, Joseph A. Cichocki, Yu-Syuan Luo, Ivan Rusyn, Weihsueh A. Chiu. PBPK modeling of impact of nonalcoholic fatty liver disease on toxicokinetics of perchloroethylene in mice. Toxicology and Applied Pharmacology 2020; 400: 115069 doi: 10.1016/j.taap.2020.115069
|
| 10 |
Bo Zhang, Fang Ding, Tian Chen, Liang-Hua Xia, Juan Qian, Guo-Yi Lv. Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat content. World Journal of Gastroenterology 2014; 20(47): 17985-17992 doi: 10.3748/wjg.v20.i47.17985
|
| 11 |
Stefano Ballestri, Dante Romagnoli, Fabio Nascimbeni, Giampiero Francica, Amedeo Lonardo. Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications. Expert Review of Gastroenterology & Hepatology 2015; 9(5): 603 doi: 10.1586/17474124.2015.1007955
|
| 12 |
Patrik Nasr, Annette Hilliges, Lars Thorelius, Stergios Kechagias, Mattias Ekstedt. Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease. Scandinavian Journal of Gastroenterology 2016; 51(9): 1126 doi: 10.3109/00365521.2016.1172336
|
| 13 |
Harshul Pandit, Joseph P. Tinney, Yan Li, Guozhen Cui, Suping Li, Bradley B. Keller, Robert C.G. Martin. Utilizing Contrast-Enhanced Ultrasound Imaging for Evaluating Fatty Liver Disease Progression in Pre-clinical Mouse Models. Ultrasound in Medicine & Biology 2019; 45(2): 549 doi: 10.1016/j.ultrasmedbio.2018.10.011
|
| 14 |
Hina Arif-Tiwari, Kristin K. Porter, Ihab R. Kamel, Mustafa R. Bashir, Alice Fung, David E. Kaplan, Brendan M. McGuire, Gregory K. Russo, Elainea N. Smith, Lilja Bjork Solnes, Kiran H. Thakrar, Abhinav Vij, Shaun A. Wahab, Richard M. Wardrop, Atif Zaheer, Laura R. Carucci. ACR Appropriateness Criteria® Abnormal Liver Function Tests. Journal of the American College of Radiology 2023; 20(11): S302 doi: 10.1016/j.jacr.2023.08.023
|
| 15 |
Sarit Anavi, Zecharia Madar, Oren Tirosh. Non-alcoholic fatty liver disease, to struggle with the strangle: Oxygen availability in fatty livers. Redox Biology 2017; 13: 386 doi: 10.1016/j.redox.2017.06.008
|
| 16 |
Monica Lupsor-Platon, Teodora Serban, Alexandra Iulia Silion, George Razvan Tirpe, Alexandru Tirpe, Mira Florea. Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease. Cancers 2021; 13(4): 790 doi: 10.3390/cancers13040790
|
| 17 |
C. Pozzessere, K.K. Porter, I.R. Kamel. Surveillance liver MRI for monitoring patients with known or suspected chronic liver disease. Clinical Radiology 2017; 72(1): 93.e7 doi: 10.1016/j.crad.2016.08.009
|
| 18 |
Hyun Joo Shin, Eun Young Chang, Hye Sun Lee, Jung Hwa Hong, Gyuri Park, Hyun Gi Kim, Myung-Joon Kim, Mi-Jung Lee. Contrast-enhanced ultrasonography for the evaluation of liver fibrosis after biliary obstruction. World Journal of Gastroenterology 2015; 21(9): 2614-2621 doi: 10.3748/wjg.v21.i9.2614
|
| 19 |
Cosmas Rinaldi Adithya Lesmana, Maria Satya Paramitha, Irsan Hasan, Andri Sanityoso Sulaiman, Rino Alvani Gani. Portal Hypertension in Non-alcoholic Fatty Liver Disease in the Era of Non-invasive Assessment. European Medical Journal 2021; : 80 doi: 10.33590/emj/21-00039
|
| 20 |
Bruno Donatini. Pullulation bactérienne du grêle. Intérêt des nouvelles technologies ambulatoires : test respiratoire couplé à l’élastométrie hépatique, à la recherche des herpès virus dans la salive ou de l’échographie gastro-intestinale. Principes thérapeutiques. Hegel 2015; (2): 92 doi: 10.3917/heg.052.0092
|
| 21 |
Shruti Tarapure, Basavaraj R. Tubaki, Siddhi Khot. Elastographic liver evaluation of Katukyadi churna in the management of Non-Alcoholic Steatohepatitis (NASH) – A single arm clinical trial.. Journal of Ayurveda and Integrative Medicine 2021; 12(1): 136 doi: 10.1016/j.jaim.2020.12.015
|
| 22 |
Ryan E. Childers, Joseph Ahn. Diagnosis of Alcoholic Liver Disease. Clinics in Liver Disease 2016; 20(3): 457 doi: 10.1016/j.cld.2016.02.005
|